Sort by

Send to

Choose Destination

Links from PubMed

Items: 11


Response trajectories to clozapine in a secondary analysis of pivotal trials support using treatment response to subtype schizophrenia.

Honer WG, Jones AA, Thornton AE, Barr AM, Procyshyn RM, Vila-Rodriguez F.

Can J Psychiatry. 2015 Mar;60(3 Suppl 2):S19-25.


Clozapine induced akathisia: a case report and review of the evidence.

Grover S, Sahoo S.

Indian J Pharmacol. 2015 Mar-Apr;47(2):234-5. doi: 10.4103/0253-7613.153441.


Concept and Management of Treatment Resistant Schizophrenia (TRS).

Painuly N, Gupta N, Avasthi A.

Indian J Psychiatry. 2004 Apr;46(2):125-34.


Are second generation antipsychotics a distinct class?

Bonham C, Abbott C.

J Psychiatr Pract. 2008 Jul;14(4):225-31. doi: 10.1097/01.pra.0000327312.04153.da. Review.


An initial animal proof-of-concept study for central administration of clozapine to schizophrenia patients.

Abrams DJ, Zheng L, Choo KS, Yang JJ, Wei W, Anchordoquy TJ, Zawia NH, Stevens KE.

Schizophr Res. 2008 Mar;100(1-3):86-96. doi: 10.1016/j.schres.2007.10.012.


Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia.

Kumra S, Oberstar JV, Sikich L, Findling RL, McClellan JM, Vinogradov S, Charles Schulz S.

Schizophr Bull. 2008 Jan;34(1):60-71. Review.


Clinical use of clozapine in a major urban setting: one year experience.

Chow EW, Collins EJ, Nuttall SE, Bassett AS.

J Psychiatry Neurosci. 1995 Mar;20(2):133-40.


Clozapine--a new and different neuroleptic.

Haller E, Binder RL.

West J Med. 1990 Jul;153(1):62-4.

Items per page

Supplemental Content

Support Center